Back to results
US 2003/0119824 A1Published application
Treatment of inflammatory bowel disease
OwnerH. Paul Redmond, Rolf W. Pfirrmanninventors
Life of this patent
Estimating the term…
Abstract
Patients suffering from inflammatory bowel disease such as Crohn's disease or ulcerative colitis are treated either orally or intravenously with methylol transfer agents, such as taurolidine and/or taurultam. These agents can be used in combination with other drugs thereby allowing the use of smaller amounts of the other drugs and limiting unwanted side effects.
Claims2
A method of treating a human infected with Crohn's disease comprising orally administering to an individual in need of such treatment an effective amount of a composition comprising taurolidine.
Dependencies are inferred from the claim text.